Clinical Trial Update: The Influence of CYP2C19 Polymorphism and Clinical Outcomes in Stroke Patients

View source ↗

Summary

A completed clinical trial examining the effect of CYP2C19 polymorphism on clinical outcomes in ischemic stroke patients treated with platelet aggregation inhib…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: National Cerebral and Cardiovascular Center, Japan | Conditions: Platelet Aggregation Inhibitors | Status: COMPLETED